CAS 535920-98-0

Varenicline carbamoyl-β-D-glucuronide

CAS: 535920-98-0

Varenicline carbamoyl-β-D-glucuronide

Peso molecular: 431.39604g/mol

Ref: 54-BICL2519

Varenicline carbamoyl b-D-glucuronide

CAS: 535920-98-0

Ref: 7W-GC3471

Varenicline Carbamoyl β-D-Glucuronide

Produto Controlado

CAS: 535920-98-0

Applications A metabolite of Varenicline.
References Toide, K., et al.: Biochem. Pharmacol., 67, 1269 (2004), Coe, J., et al.: J. Med. Chem., 48, 3474 (2005), Doll, R., et al.: Br. J. Cancer, 92, 426 (2005), Obach, R., et al.: Drug Metab. Dispos., 33, 262 (2005),

Fórmula: C₂₀H₂₁N₃O₈

Cor e Forma: Neat

Peso molecular: 431.4

Ref: TR-V098485

Varenicline carbamoyl b-D-glucuronide

CAS: 535920-98-0

Varenicline is a glycosylation product with a sugar, which is synthesized by the methylation and fluorination of carbamoyl b-D-glucuronide. This drug is used for the treatment of nicotine dependence in adults. It acts on nicotinic acetylcholine receptors in the brain to reduce cravings and withdrawal symptoms from smoking, as well as increasing the release of dopamine. Varenicline binds to alpha4beta2 nicotinic acetylcholine receptors, which are located in the brain and other organs, such as the stomach and pancreas. The drug has been shown to be effective for smoking cessation when used alone or in combination with nicotine replacement therapy.

Fórmula: C₂₀H₂₁N₃O₈

Pureza: Min. 95%

Peso molecular: 431.4 g/mol

Ref: 3D-MV16890

Varenicline Carbamoyl β-D-Glucuronide

CAS: 535920-98-0

Fórmula: C₂₀H₂₁N₃O₈

Peso molecular: 431.4

Ref: ST-EA-CP-V8045